Asparia Glycomics
PrivateLast Round
Accelerator
May 23, 2018
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Asparia Glycomics operates in Healthcare & Life Sciences and is based in Donostia-San Sebastián. Its latest recorded funding round was an Accelerator round in May 2018.
Asparia Glycomics is a biotechnology company that provides custom glycan synthesis, glycan analysis services, and glycotechnology products for pharmaceutical, biotech, and research organizations.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Asparia Glycomics Comparables
Compare Asparia Glycomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Chemily Glycoscience | 89% | |
| Z Biotech, LLC | 86% | |
| Sussex Research Laboratories Inc. | 85% |
For institutional investors. Book with your work email.
Asparia Glycomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | May 23, 2018 | ||||
| Seed | Dec 21, 2016 |
For institutional investors. Book with your work email.
Asparia Glycomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MassChallenge Israel | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 47% MoM.
- Jun 21, 2026
Monthly visitors increased 1435% MoM.
For institutional investors. Book with your work email.
Asparia Glycomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Asparia Glycomics's valuation, stock price, and market status.
Is Asparia Glycomics a public or private company?
Asparia Glycomics is a private company.
What is the current stock price of Asparia Glycomics?
Asparia Glycomics is a private company, so its shares have no public market price. Caplight tracks Asparia Glycomics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Asparia Glycomics worth (valuation)?
Valuation information for Asparia Glycomics is not publicly available.
Can I buy Asparia Glycomics stock?
Asparia Glycomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Asparia Glycomics's last funding round?
Asparia Glycomics's most recent funding round was Accelerator on May 23, 2018.
Who are the main investors in Asparia Glycomics?
Key investors in Asparia Glycomics include MassChallenge Israel.
Will Asparia Glycomics IPO soon?
No public IPO plans have been announced for Asparia Glycomics.
How can I track Asparia Glycomics secondary market activity?
Caplight tracks bids, offers, and trades in Asparia Glycomics's shares on secondary markets.